Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Bisoprolol vs IV Diltiazem for AF/Flutter with RVR
NCT06276127Phase 3Not yet recruiting
- Sponsor
- Oman Medical Specialty Board
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bisoprolol in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Oman Medical Specialty Board. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
bisoprolol
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT06276127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276127.